from Reuters: Health News http://reut.rs/2ALoHXT
Europe approves GlaxoSmithKline's new triple lung drug
By
LONDON (Reuters) - Europe has approved GlaxoSmithKline's new three-in-one inhaler for chronic lung disease, which the group hopes will help it keep its lead in respiratory medicine despite falling sales of older drug Advair.
from Reuters: Health News http://reut.rs/2ALoHXT
from Reuters: Health News http://reut.rs/2ALoHXT
Like This Post? Please share!
0 comments:
Post a Comment